2024 CMCR Symposium Agenda

 

Click here to Register

 

Day 1: Thursday, October 17, 2024

8:00-8:05 Welcome from the CMCR Director, Igor Grant, MD 

2024 CMCR Symposium Awards

8:05-8:40 Alexandros Makriyannis, PhD - CMCR Pioneer in Medicinal Cannabis Research Award

Presentation of Award and Keynote Address 

This award honors leaders in cannabis and cannabinoid research conducting basic and translational research of cannabinoids, other constituents of cannabis, and the endocannabinoid system. The recipient’s work has led to significant advancements in our understanding of the mechanism and physiological effects of cannabinoids and related compounds.

8:40-9:15  Mark Ware, MD, MRCP(UK), MSc - CMCR Award for Advancing Cannabis and Cannabinoids as Therapeutics 

Presentation of Award and Keynote Address 

This award honors those whose work has led to significant changes in our knowledge of or an expansion to the therapeutic use of cannabis and cannabinoid-based medicines. Recipients come from a diverse array of backgrounds, including drug development, medicine, public policy, and advocacy.

9:15-9:55 Moderated panel discussion and Q&A with 2024 CMCR Symposium Award Recipients & previous award recipients 

2023 Award Recipients: Marilyn Huestis, PhD and Margaret (Meg) Haney, PhD

2022 Award Recipients: Daniele Piomelli, PhD and Donald Abrams, MD

2019 Award Recipients: Geoffrey Guy, MD

9:55-10:00 5-minute break

CMCR Special Lectures

10:00-10:20 Nathaniel Schuster, MD - A randomized clinical trial of cannabis for migraine headaches

10:20-10:30 Q&A with Mark Wallace, MD (Dr. Schuster's collaborator) moderated by J. Hampton Atkinson, MD

10:30-10:50 Veena Ranganath, MD, MS - A randomized clinical trial of cannabidiol to reduce joint inflammation in rheumatoid arthritis

10:50-11:00 Q&A moderated by J. Hampton Atkinson, MD

Healthy Aging

11:00-11:15 Alison Moore, MD, MPH, FACP - A perspective on cannabis and healthy aging

11:15-11:30 Kim Finley, PhD - Impact of cannabinoids on Drosophila longevity and traumatic injury response

11:30-11:45 Michael Petracheck, PhD - Induction of C. elegans longevity by endocannabinoid modulators 

11:45-11:55 Moderated panel discussion with the speakers  and Q&A

12:00-1:00 Poster Session 

 


Day 2: Friday, October 18, 2024

Dementia

8:00-8:15 Pamela Maher, PhD - Efficacy of cannabinoids in a pre-clinical drug-screening platform for Alzheimer's Disease

8:15-8:30 Krista L. Lanctot, PhD - Randomized clinical trial of nabilone for the treatment of agitation in dementia

8:30-8:45 Brent Forester, MD, MSc - Randomized clinical trial of dronabinol for the treatment of agitation in dementia

8:45-8:55 Moderated panel discussion with the speakers  and Q&A

8:55-9:00 5-minute break

Cancer Treatment

9:00-9:15 Nephi Stella, PhD - Anti-tumor activity of cannabinoid-based molecules

9:15-9:30 Chris Twelves, PhD - Nabiximols with temozolomide in patients with recurrent glioblastoma

9:30-9:45 Joseph A. Califano, MD - Diverse effects of cannabinoids on head and neck squamous cell carcinoma

9:45-9:55 Moderated panel discussion with the speakers  and Q&A

9:55-10:00 5-minute break

Use of cannabis and cannabinoids among older adults and people with cancer

10:00-10:15 Ilana Braun, MD - Cannabis and cannabinoids in adults with cancer

10:00-10:15 Patricia Di Ciano, PhD - Cannabis and driving in older adults

10:00-10:15 Linda Hill, MD, MPH - Impact of recreational cannabis use legalization on older adults in California 

10:45-10:55 Moderated panel discussion with the speakers  and Q&A

10:55-11:00 5-minute break

NIH Institute Panel

11:00-11:55  Panel discussion and Q&A moderated by Steve Gust, PhD, Advisor to CMCR

The invited Federal stakeholders will discuss future directions in funding for medicinal cannabis and new directions in aging and cancer care featuring the following panelists:

Alexis Bakos, PhD, MPH, RN, Program Director, Division of Geriatrics and Clinical Gerontology, National Institute on Aging

Andrew Freedman, PhD, Chief, Epidemiology and Genomics Research Program, Clinical and Translational Epidemiology Branch, National Cancer Institute

David Shurtleff, PhD, National Center on Complementary and Integrative Health (NCCIH)

Susan Weiss, PhD, Director, Division of Extramural Research, National Institute on Drug Abuse

11:55-12:00 Closing Remarks from the CMCR Director, Igor Grant, MD 

 

2024 Speaker Bios - coming soon

2024 CMCR Symposium Sponsors - coming soon

LINK to past CMCR Symposia